We report the case of a 6-week-old female who presented an intracranial hemorrhage due to late vitamin K deficiency bleeding (VKDB). No other evident bleeding sites were present at the moment of diagnosis. Intramuscular vitamin K (1 mg) was administered at birth. She was exclusively breast-fed. No other risk factors for VKDB were detected. Low levels of vitamin K-dependent coagulation factors and their normalization after vitamin K administration confirmed the diagnosis of late VKDB. The present case suggests potential risks related to a single dose of intramuscular vitamin K at birth.
Introduction
Late vitamin K deficiency bleeding (VKDB) is a rare syndrome defined as unexpected bleeding attributable to a reduction of vitamin K-dependent coagulation factors in infants 2 to 12 weeks of age. The incidence of late VKDB ranges from 4.4 to 7.2 per 1 00 000 births, and it usually occurs in breast-fed babies who have not received vitamin K at birth. The clinical presentation of late VKDB is characterized, in about 50 to 60% of cases, by sudden intracranial hemorrhage. 1 Oral vitamin K at birth reduces the incidence of the classical form, but there is a residual risk of late VKDB. Intramuscular (im) administration of vitamin K (1 mg) at birth theoretically prevents the development of late VKDB, with the exception of infants with severe intestinal malabsorption such as in cystic fibrosis and cholestatic jaundice. [1] [2] [3] [4] However, recent studies report low levels of vitamin K even 2 to 3 weeks after birth in newborns exclusively breastfed who received im prophylaxis at birth. 5 Case Report A 6-week-old female girl was admitted to our hospital with irritability, axial hypertonus and exotropia. She was a term newborn, delivered spontaneously. One milligram of im vitamin K had been given immediately after birth. The baby had been exclusively breast-fed since birth and had not received any oral supplementation of vitamin K. Postnatal growth was adequate, and there was no history of prolonged jaundice, intestinal disorders or previous trauma. No family history of coagulopathy was reported.
Physical examination revealed bulging anterior fontanelle, axial hypertonus, exotropia, pallor and partial seizures. No evident external bleeding was found.
The cerebral ultrasound and computerized tomography scan showed massive intraventricular hemorrhage involving all four ventricles, in the absence of any evident congenital malformation ( Figure 1 ).
Blood examination performed at the moment of admission showed anemia (hemoglobin 9.6 g per 100 ml, hematocrit 28.8%), normal platelet count (4 74 000 per mmc) and fibrinogen levels (262 mg per 100 ml). Clotting function was abnormal (prothrombin time (PT) 28%, activated partial thromboplastin time (aPTT) 46 s, international normalized ratio (INR) 2.29; Factor II 8%, factor VII 12%, factor V 120%; Table 1 ).
Considering the low levels of vitamin K-dependent clotting factors, 2 mg of im vitamin K was administered. No progression of intracranial bleeding was observed.
Serial cerebral ultrasounds demonstrated absorption of the intraventricular blood and, subsequently, a posthemorrhagic noncommunicating hydrocephalus (Figure 2) . The newborn underwent a ventriculoperitoneal shunt with good long-term outcome.
Clotting function at the moment of discharge (about 1 month later) was normal (PT 99%, aPTT 28 s, INR 1.01. Factor II 82%, factor VII 89%; Table 1 ).
Daily dose of 25 mg of oral vitamin K was prescribed until the 14th week and no further bleeding episodes occurred.
Discussion
Late VKDB should be suspected when an intracranial hemorrhage in a previously healthy newborn is found. Central nervous bleeding is the first clinical manifestation of late VKBW in about 50 to 60% of cases. This 6-week-old female newborn had no medical history of prolonged jaundice, bowel or liver diseases. Normal levels of clotting factor V excluded liver dysfunction, whereas adequate postnatal growth ruled out malabsorption. Neither history of trauma nor cerebral venous malformations were present. A correct prophylaxis had been performed at birth and the only risk factor for late VKDB was breastfeeding not associated with oral vitamin K supplementation.
Low levels of vitamin K-dependent clotting factors suggested a late onset form of VKDW. Moreover, normalization of factor II and VII after 2 mg of im vitamin K confirmed the clinical suspicion.
Current guidelines issued by the American Academy of Pediatrics suggest a single dose of 1 mg at birth to prevent VKDB. [1] [2] [3] [4] However, cases of VKDB in exclusively breastfed healthy newborns, despite im prophylaxis at birth, have been described. 6, 7 Vitamin K concentration in breast milk are considerably lower than those present in infant formulas (2 vs 25 to 60 mg l À1 ). 5 This may lead to reductions in vitamin K plasma concentration in exclusively breastfed newborns 3 to 4 weeks after birth. 8 Our case report suggests that prophylaxis with a single dose of im vitamin K may be inadequate to prevent all cases of late VKBD. Some authors have suggested an oral supplementation of vitamin K to all lactating mothers to increase vitamin K levels in breast milk, 8 even though definitive data in support of such an approach are lacking. Starting in 2004, the Italian Society of Neonatology recommends an oral administration of vitamin K in all exclusively breast-fed newborns in the period from the 2nd to 14th weeks of age. [9] [10] [11] Nevertheless, further studies to assess the safety and efficacy of oral administration of vitamin K after im prophylaxis at birth are necessary. Figure 2 Posthemorrhagic noncommunicating hydrocephalus.
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